AKT1 and liver cancer: This study discovered that CBD forms stable hydrophobic and hydrogen bond interactions within the catalytic domain of Akt-2, suggesting that CBD’s anti-angiogenic, pro-apoptotic, cell cycle arrest, and anti-inflammatory effects in liver cancer animal models may be associated with Akt.